Celularity Inc. (CELU:NASDAQ) closed at $1.25 on October 16, 2026, down 6.02% on the day. The stock trades 51.0% below its 52-week high of $2.55 and 123.2% above its 52-week low of $0.560. Over the past year, it lost 36.9%. Celularity Inc. is part of the Finance sector.
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -14.97% | -1.57% | +60.26% | +0.81% | -36.87% |
In 252 trading sessions since October 16, 2025, CELU closed higher on 108 days (43%). Its best day was August 27, 2026 (+138.64%) and its worst was August 28, 2026 (-24.76%). The stock moved 10% or more in a single session 22 times. It opened at least 5% above the previous day's high 1 time.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases.
Find more stocks like CELU with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.